The system may be used as an adjunct to fusion in numerous degenerative and complex spinal pathologies. It is intended to help address single, complex and multi-level spinal pathologies with minimal tissue disruption and trauma.
A full market launch of the Avance system is planned for the fourth quarter of 2014, with limited market release in the second and third quarter of 2014.
Baxano Surgical is a medical device company focused on designing, developing and marketing minimally invasive solutions to treat degenerative conditions of the lumbar spine.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
